Annual Net Income
-$74.66 M
+$115.44 M+60.73%
31 December 2023
Summary:
Standard BioTools annual net profit is currently -$74.66 million, with the most recent change of +$115.44 million (+60.73%) on 31 December 2023. During the last 3 years, it has fallen by -$21.64 million (-40.81%). LAB annual net income is now -351.75% below its all-time high of -$16.53 million, reached on 01 December 2013.LAB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$26.94 M
+$18.78 M+41.08%
30 September 2024
Summary:
Standard BioTools quarterly net profit is currently -$26.94 million, with the most recent change of +$18.78 million (+41.08%) on 30 September 2024. Over the past year, it has dropped by -$5.94 million (-28.29%). LAB quarterly net income is now -775.18% below its all-time high of -$3.08 million, reached on 01 December 2010.LAB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$124.59 M
-$5.94 M-5.01%
30 September 2024
Summary:
Standard BioTools TTM net profit is currently -$124.59 million, with the most recent change of -$5.94 million (-5.01%) on 30 September 2024. Over the past year, it has dropped by -$48.86 million (-64.53%). LAB TTM net income is now -3534.45% below its all-time high of -$3.43 million, reached on 01 December 2009.LAB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LAB Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.7% | -28.3% | -64.5% |
| 3 y3 years | -40.8% | -94.6% | -83.7% |
| 5 y5 years | -26.5% | -112.4% | -92.3% |
LAB Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -40.8% | +60.7% | -185.7% | +64.7% | -110.3% | +34.5% |
| 5 y | 5 years | -40.8% | +60.7% | -349.0% | +64.7% | -161.3% | +34.5% |
| alltime | all time | -351.8% | +60.7% | -775.2% | +64.7% | -3534.4% | +34.5% |
Standard BioTools Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$26.94 M(-41.1%) | -$124.59 M(+5.0%) |
| June 2024 | - | -$45.72 M(+42.2%) | -$118.65 M(+31.9%) |
| Mar 2024 | - | -$32.16 M(+62.6%) | -$89.97 M(+20.5%) |
| Dec 2023 | -$74.66 M(-60.7%) | -$19.78 M(-5.8%) | -$74.66 M(-1.4%) |
| Sept 2023 | - | -$21.00 M(+23.2%) | -$75.72 M(-10.0%) |
| June 2023 | - | -$17.04 M(+1.2%) | -$84.15 M(-35.6%) |
| Mar 2023 | - | -$16.84 M(-19.2%) | -$130.65 M(-31.3%) |
| Dec 2022 | -$190.10 M(+220.9%) | -$20.84 M(-29.2%) | -$190.10 M(+6.4%) |
| Sept 2022 | - | -$29.43 M(-53.7%) | -$178.68 M(+9.6%) |
| June 2022 | - | -$63.54 M(-16.7%) | -$163.10 M(+39.8%) |
| Mar 2022 | - | -$76.29 M(+709.1%) | -$116.70 M(+97.0%) |
| Dec 2021 | -$59.24 M(+11.7%) | -$9.43 M(-31.9%) | -$59.24 M(-12.7%) |
| Sept 2021 | - | -$13.84 M(-19.2%) | -$67.83 M(+13.1%) |
| June 2021 | - | -$17.14 M(-8.9%) | -$59.99 M(+7.4%) |
| Mar 2021 | - | -$18.82 M(+4.4%) | -$55.86 M(+5.4%) |
| Dec 2020 | -$53.02 M(-18.2%) | - | - |
| Dec 2020 | - | -$18.03 M(+200.5%) | -$53.02 M(+11.2%) |
| Sept 2020 | - | -$6.00 M(-53.9%) | -$47.68 M(-12.6%) |
| June 2020 | - | -$13.02 M(-18.6%) | -$54.57 M(-1.3%) |
| Mar 2020 | - | -$15.98 M(+26.0%) | -$55.30 M(-14.6%) |
| Dec 2019 | -$64.79 M(+9.8%) | - | - |
| Dec 2019 | - | -$12.69 M(-1.6%) | -$64.79 M(-3.1%) |
| Sept 2019 | - | -$12.89 M(-6.3%) | -$66.88 M(-2.7%) |
| June 2019 | - | -$13.75 M(-46.0%) | -$68.74 M(-3.5%) |
| Mar 2019 | - | -$25.46 M(+72.4%) | -$71.23 M(+20.7%) |
| Dec 2018 | -$59.01 M(-2.5%) | -$14.78 M(+0.2%) | -$59.01 M(+7.9%) |
| Sept 2018 | - | -$14.75 M(-9.2%) | -$54.70 M(-2.1%) |
| June 2018 | - | -$16.24 M(+22.6%) | -$55.89 M(-1.2%) |
| Mar 2018 | - | -$13.25 M(+26.7%) | -$56.58 M(-6.5%) |
| Dec 2017 | -$60.53 M | -$10.46 M(-34.4%) | -$60.54 M(-10.7%) |
| Sept 2017 | - | -$15.94 M(-5.8%) | -$67.78 M(-5.4%) |
| June 2017 | - | -$16.93 M(-1.6%) | -$71.62 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$17.20 M(-2.8%) | -$73.30 M(-3.5%) |
| Dec 2016 | -$75.98 M(+42.5%) | -$17.70 M(-10.6%) | -$75.99 M(+6.8%) |
| Sept 2016 | - | -$19.79 M(+6.3%) | -$71.17 M(+17.3%) |
| June 2016 | - | -$18.62 M(-6.4%) | -$60.65 M(+5.9%) |
| Mar 2016 | - | -$19.88 M(+54.4%) | -$57.27 M(+7.4%) |
| Dec 2015 | -$53.31 M(+0.9%) | -$12.88 M(+38.9%) | -$53.31 M(+3.8%) |
| Sept 2015 | - | -$9.27 M(-39.2%) | -$51.38 M(-8.1%) |
| June 2015 | - | -$15.24 M(-4.4%) | -$55.90 M(+4.8%) |
| Mar 2015 | - | -$15.93 M(+45.6%) | -$53.35 M(+1.0%) |
| Dec 2014 | -$52.83 M(+219.7%) | -$10.94 M(-20.6%) | -$52.83 M(+13.5%) |
| Sept 2014 | - | -$13.79 M(+8.7%) | -$46.53 M(+25.7%) |
| June 2014 | - | -$12.68 M(-17.7%) | -$37.02 M(+30.4%) |
| Mar 2014 | - | -$15.41 M(+232.0%) | -$28.39 M(+71.8%) |
| Dec 2013 | -$16.53 M(-13.1%) | -$4.64 M(+8.3%) | -$16.53 M(+6.7%) |
| Sept 2013 | - | -$4.29 M(+5.9%) | -$15.48 M(+0.9%) |
| June 2013 | - | -$4.05 M(+13.9%) | -$15.35 M(-3.4%) |
| Mar 2013 | - | -$3.55 M(-1.4%) | -$15.88 M(-16.5%) |
| Dec 2012 | -$19.02 M(-15.3%) | -$3.60 M(-13.2%) | -$19.02 M(+0.8%) |
| Sept 2012 | - | -$4.15 M(-9.3%) | -$18.88 M(-1.8%) |
| June 2012 | - | -$4.58 M(-31.5%) | -$19.22 M(-11.9%) |
| Mar 2012 | - | -$6.69 M(+93.5%) | -$21.82 M(-2.9%) |
| Dec 2011 | -$22.47 M(+32.9%) | -$3.46 M(-23.0%) | -$22.47 M(+1.7%) |
| Sept 2011 | - | -$4.49 M(-37.5%) | -$22.09 M(+5.3%) |
| June 2011 | - | -$7.19 M(-2.1%) | -$20.98 M(+12.7%) |
| Mar 2011 | - | -$7.34 M(+138.4%) | -$18.61 M(+10.1%) |
| Dec 2010 | -$16.90 M(-11.6%) | -$3.08 M(-8.9%) | -$16.90 M(-2.0%) |
| Sept 2010 | - | -$3.38 M(-29.9%) | -$17.25 M(+24.4%) |
| June 2010 | - | -$4.82 M(-14.3%) | -$13.87 M(+53.2%) |
| Mar 2010 | - | -$5.63 M(+64.1%) | -$9.05 M(+164.1%) |
| Dec 2009 | -$19.13 M(-35.2%) | -$3.43 M | -$3.43 M |
| Dec 2008 | -$29.50 M(+15.9%) | - | - |
| Dec 2007 | -$25.45 M(+8.1%) | - | - |
| Dec 2006 | -$23.55 M | - | - |
FAQ
- What is Standard BioTools annual net profit?
- What is the all time high annual net income for Standard BioTools?
- What is Standard BioTools annual net income year-on-year change?
- What is Standard BioTools quarterly net profit?
- What is the all time high quarterly net income for Standard BioTools?
- What is Standard BioTools quarterly net income year-on-year change?
- What is Standard BioTools TTM net profit?
- What is the all time high TTM net income for Standard BioTools?
- What is Standard BioTools TTM net income year-on-year change?
What is Standard BioTools annual net profit?
The current annual net income of LAB is -$74.66 M
What is the all time high annual net income for Standard BioTools?
Standard BioTools all-time high annual net profit is -$16.53 M
What is Standard BioTools annual net income year-on-year change?
Over the past year, LAB annual net profit has changed by +$115.44 M (+60.73%)
What is Standard BioTools quarterly net profit?
The current quarterly net income of LAB is -$26.94 M
What is the all time high quarterly net income for Standard BioTools?
Standard BioTools all-time high quarterly net profit is -$3.08 M
What is Standard BioTools quarterly net income year-on-year change?
Over the past year, LAB quarterly net profit has changed by -$5.94 M (-28.29%)
What is Standard BioTools TTM net profit?
The current TTM net income of LAB is -$124.59 M
What is the all time high TTM net income for Standard BioTools?
Standard BioTools all-time high TTM net profit is -$3.43 M
What is Standard BioTools TTM net income year-on-year change?
Over the past year, LAB TTM net profit has changed by -$48.86 M (-64.53%)